Polyneuron Pharmaceuticals ^Company

Polyneuron is pioneering a novel therapeutic approach for the effective and safe treatment of antibody-mediated autoimmune diseases where a pathological role of autoantibodies is well established. Polyneuron’s platform focus is on devastating autoimmune diseases with an unmet medical need. The company’s Antibody-Catch™ technology platform enables the chemical design of injectable glycopolymers that are able to selectively eliminate the pathological autoantibodies, while leaving the rest of the immune system intact.